• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Circulating tumor cells in bladder cancer: a new horizon of liquid biopsy for precision medicine.

作者信息

Crocetto Felice, Cimmino Amelia, Ferro Matteo, Terracciano Daniela

机构信息

Department of Neurosciences, Sciences of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.

Institute of Genetics and Biophysics, National Research Council, Naples, Italy.

出版信息

J Basic Clin Physiol Pharmacol. 2021 Sep 27;33(5):525-527. doi: 10.1515/jbcpp-2021-0233. eCollection 2022 Sep 1.

DOI:10.1515/jbcpp-2021-0233
PMID:34563104
Abstract
摘要

相似文献

1
Circulating tumor cells in bladder cancer: a new horizon of liquid biopsy for precision medicine.膀胱癌中的循环肿瘤细胞：精准医学液体活检的新视野。
J Basic Clin Physiol Pharmacol. 2021 Sep 27;33(5):525-527. doi: 10.1515/jbcpp-2021-0233. eCollection 2022 Sep 1.
2
Liquid biopsy in the clinical management of bladder cancer: current status and future developments.液体活检在膀胱癌临床管理中的应用：现状与未来发展。
Expert Rev Mol Diagn. 2020 Feb;20(2):255-264. doi: 10.1080/14737159.2019.1680284. Epub 2019 Oct 17.
3
Liquid biopsy accelerates precision medicine.液体活检加速精准医疗。
Ann Oncol. 2023 Apr;34(4):333-335. doi: 10.1016/j.annonc.2023.02.004. Epub 2023 Feb 16.
4
Liquid Biopsy: From Basic Research to Clinical Practice.液体活检：从基础研究到临床实践。
Adv Clin Chem. 2018;83:73-119. doi: 10.1016/bs.acc.2017.10.003. Epub 2017 Nov 23.
5
The Future of Precision Medicine in Oncology.肿瘤学中精准医学的未来。
Clin Lab Med. 2016 Sep;36(3):557-73. doi: 10.1016/j.cll.2016.05.003.
6
Application of liquid biopsy in precision medicine: opportunities and challenges.液体活检在精准医学中的应用：机遇与挑战。
Front Med. 2017 Dec;11(4):522-527. doi: 10.1007/s11684-017-0526-7. Epub 2017 Jul 25.
7
Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine.液体活检在精准医学中的应用前景与挑战
Cancer Res. 2019 Jun 1;79(11):2798-2804. doi: 10.1158/0008-5472.CAN-18-3402. Epub 2019 May 20.
8
Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy.液体活检推动非小细胞肺癌精准治疗。
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818801809. doi: 10.1177/1533033818801809.
9
Bladder cancer: The promise of liquid biopsy ctDNA analysis.膀胱癌：液体活检ctDNA分析的前景
Nat Rev Urol. 2017 Oct;14(10):580-581. doi: 10.1038/nrurol.2017.138. Epub 2017 Aug 16.
10
Liquid Biopsy Based on Circulating Cancer-Associated Cells: Bridging the Gap from an Emerging Concept to a Mainstream Tool in Precision Medicine.基于循环肿瘤相关细胞的液体活检：从新兴概念到精准医学主流工具的桥梁。
Adv Biosyst. 2020 Feb;4(2):e1900164. doi: 10.1002/adbi.201900164. Epub 2019 Dec 20.

引用本文的文献

1
Circulating miRNAs in genitourinary cancer: pioneering advances in early detection and diagnosis.泌尿生殖系统癌症中的循环微小RNA：早期检测与诊断的开创性进展
J Liq Biopsy. 2025 Apr 25;8:100296. doi: 10.1016/j.jlb.2025.100296. eCollection 2025 Jun.
2
Liquid Biopsy as a New Tool for Diagnosis and Monitoring in Renal Cell Carcinoma.液体活检作为肾细胞癌诊断和监测的新工具
Cancers (Basel). 2025 Apr 25;17(9):1442. doi: 10.3390/cancers17091442.
3
The predictive value of PFKFB3 in bladder cancer prognosis.磷酸果糖激酶-2/果糖-2,6-二磷酸酶3（PFKFB3）在膀胱癌预后中的预测价值。
Heliyon. 2024 May 15;10(10):e31347. doi: 10.1016/j.heliyon.2024.e31347. eCollection 2024 May 30.
4
Unlocking Precision Medicine: Liquid Biopsy Advancements in Renal Cancer Detection and Monitoring.解锁精准医学：液体活检在肾癌检测和监测中的进展。
Int J Mol Sci. 2024 Mar 30;25(7):3867. doi: 10.3390/ijms25073867.
5
Hypermethylation Loci of ZNF671, IRF8, and OTX1 as Potential Urine-Based Predictive Biomarkers for Bladder Cancer.ZNF671、IRF8和OTX1的高甲基化位点作为基于尿液的膀胱癌潜在预测生物标志物
Diagnostics (Basel). 2024 Feb 21;14(5):468. doi: 10.3390/diagnostics14050468.
6
Survival and clinicopathological significance of B7-H3 in bladder cancer: a systematic review and meta-analysis.B7-H3在膀胱癌中的生存及临床病理意义：一项系统评价与Meta分析
BMC Urol. 2024 Mar 11;24(1):57. doi: 10.1186/s12894-024-01446-3.
7
New Perspectives on the Role of Liquid Biopsy in Bladder Cancer: Applicability to Precision Medicine.液体活检在膀胱癌中的作用新视角：对精准医学的适用性
Cancers (Basel). 2024 Feb 16;16(4):803. doi: 10.3390/cancers16040803.
8
Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.一种新的明确的炎症相关长链非编码RNA特征的鉴定有助于预测膀胱癌的预后以及区分冷肿瘤和热肿瘤。
Front Oncol. 2023 Mar 29;13:972558. doi: 10.3389/fonc.2023.972558. eCollection 2023.
9
Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A Review.循环肿瘤细胞、尿液 microRNA 和尿液游离 DNA 对膀胱癌的诊断潜力：综述。
Int J Mol Sci. 2022 Aug 15;23(16):9148. doi: 10.3390/ijms23169148.
10
Circulating Tumor DNA-Based Genomic Profiling Assays in Adult Solid Tumors for Precision Oncology: Recent Advancements and Future Challenges.基于循环肿瘤DNA的成人实体瘤基因组分析检测在精准肿瘤学中的应用：最新进展与未来挑战
Cancers (Basel). 2022 Jul 4;14(13):3275. doi: 10.3390/cancers14133275.